Downregulation of VEGF-A, STAT5 and AKT in acute myeloid leukemia blasts of patients treated with SU5416

References

• Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27–31
   PubMed Web of Science ®Google Scholar
• Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671–674
   PubMed Web of Science ®Google Scholar
• Fiedler W, Graeven U, Ergun S, Verago S, Kilic N, Stockschlader M, et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 1997; 89: 1870–1875
   PubMed Web of Science ®Google Scholar
• Padro T, Ruiz S, Bieker R, Burger H, Steins M, Kienast J, et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000; 95: 2637–2644
   PubMed Web of Science ®Google Scholar
• Yancopoulos G D, Davis S, Gale N W, Rudge J S, Wiegand S J, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242–248
   PubMed Web of Science ®Google Scholar
• Dias S, Hattori K, Heissig B, Zhu Z, Wu Y, Witte L, et al. Inhibition of both paracrine and autocrine VEGF/VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Proc Natl Acad Sci USA 2001; 98: 10857–10862
   PubMed Web of Science ®Google Scholar
• Santos S C, Dias S. Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways. Blood 2004; 103: 3883–3889
   PubMed Web of Science ®Google Scholar
• Aguayo A, Estey E, Kantarjian H, Mansouri T, Gidel C, Keating M, et al. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood 1999; 94: 3717–3721
   PubMed Web of Science ®Google Scholar
• Ward A C, Touw I, Yoshimura A. The Jak-Stat pathway in normal and perturbed hematopoiesis. Blood 2000; 95: 19–29
   PubMed Web of Science ®Google Scholar
• Meyer J, Jücker M, Ostertag W, Stocking C. Carboxyl-truncated STAT5beta is generated by a nucleus-associated serine protease in early hematopoietic progenitors. Blood 1998; 91: 1901–1908
   PubMed Web of Science ®Google Scholar
• Cantley L C, Neel B G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 1999; 96: 4240–4245
   PubMed Web of Science ®Google Scholar
• Chang F, Lee J T, Navolanic P M, Steelman L S, Shelton J G, Blalock W L, et al. Involvement of PI3K/AKT pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 2003; 17: 590–603
   PubMed Web of Science ®Google Scholar
• Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi J K, et al. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3 k/AKT-dependent pathway. EMBO J 1997; 16: 6151–6161
   PubMed Web of Science ®Google Scholar
• Fiedler W, Mesters R, Tinnefeld H, Loges S, Staib P, Duhrsen U, et al. A phase II clinical study of SU5416 in patients with refractory acute myeloid leukemia. Blood 2003; 102: 2763–2767
   PubMed Web of Science ®Google Scholar
• Avanzi G C, Lista P, Giovinazzo B, Miniero R, Saglio G, Benetton G. Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features. Br J Haematol 1988; 69: 359–366
   PubMed Web of Science ®Google Scholar
• Avanzi G C, Brizzi M F, Giannotti J, Ciarletta A, Yang Y C, Pegoraro L, et al. M-07e human leukemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3. J Cell Physiol 1990; 145: 458–464
   PubMed Web of Science ®Google Scholar
• Rozen S, Skaletsky H. Primer3 on the WWW for general users and biologist programmers. Bioinformatics methods and protocols: methods in molecular biology, S Krawetz, S Misener. Humana Press, Totowa, NJ 2000; 365–386
   Google Scholar
• Jücker M, Feldman R A. Identification of a new adapter protein that may link the common beta subunit of the receptor for granulocyte/macrophage colony-stimulating factor, interleukin (IL)- 3, and IL-5 to phosphatidylinositol 3-kinase. J Biol Chem 1995; 270: 27817–27822
   PubMed Web of Science ®Google Scholar
• Dias S, Hattori K, Zhu Z, Heissig B, Choy M, Lane W, et al. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest 2000; 106: 511–521
   PubMed Web of Science ®Google Scholar
• Zhong X S, Zheng J Z, Reed E, Jiang B H. SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway. Biochem Biophys Res Commun 2004; 324: 471–480
   PubMed Web of Science ®Google Scholar
• Fiedler W, Serve H, Dohner H, Schwittay M, Ottmann O G, O'Farrell A M, et al. A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease. Blood 2005; 105: 986–993
   PubMed Web of Science ®Google Scholar
• Peterson A C, Swiger S, Stadler W M, Medved M, Karczmar G, Gajewski T F. Phase II study of the Flk-1 tyrosine kinase inhibitor SU5416 in advanced melanoma. Clin Cancer Res 2004; 10: 4048–4054
   PubMed Web of Science ®Google Scholar
• Barleon B, Reusch P, Totzke F, Herzog C, Keck C, Martiny-Baron G, et al. Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors. Angiogenesis 2001; 4: 143–154
   PubMedGoogle Scholar
• Clauss M, Pipp F, Issbrucker K, Weich H, Heil M, Schaper W. Dissection of monocyte and endothelial activities by using VEGF-receptor specific ligands. Adv Exp Med Biol 2003; 522: 75–82
   PubMed Web of Science ®Google Scholar
• Harmey J H, Dimitriadis E, Kay E, Redmond H P, Bouchier-Hayes D. Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1. Ann Surg Oncol 1998; 5: 271–278
   PubMed Web of Science ®Google Scholar
• Melter M, Reinders M E, Sho M, Pal S, Geehan C, Denton M D, et al. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood 2000; 96: 3801–3808
   PubMed Web of Science ®Google Scholar
• Kapur R, Zhang L. A novel mechanism of cooperation between c-Kit and erythropoietin receptor. Stem cell factor induces the expression of Stat5 and erythropoietin receptor, resulting in efficient proliferation and survival by erythropoietin. J Biol Chem 2001; 276: 1099–1106
   PubMed Web of Science ®Google Scholar
• Smolich B D, Yuen H A, West K A, Giles F J, Albitar M, Cherrington J M. The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts. Blood 2001; 97: 1413–1421
   PubMed Web of Science ®Google Scholar
• Crispi S, Sanzari E, Monfregola J, De Felice N, Fimiani G, Ambrosio R, et al. Characterization of the human STAT5 A and STAT5B promoters: evidence of a positive and negative mechanism of transcriptional regulation. FEBS Lett 2004; 562: 27–34
   PubMed Web of Science ®Google Scholar
• Finkenzeller G, Sparacio A, Technau A, Marme D, Siemeister G. Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene 1997; 15: 669–676
   PubMed Web of Science ®Google Scholar
• Schafer G, Cramer T, Suske G, Kemmner W, Wiedenmann B, Hocker M. Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1- and Sp3-dependent activation of two proximal GC-rich promoter elements. J Biol Chem 2003; 278: 8190–8198
   PubMed Web of Science ®Google Scholar
• Legros L, Bourcier C, Jacquel A, Mahon F X, Cassuto J P, Auberger P, et al. Imatinib mesylate (STI571) decreases the vascular endothelial growth factor plasma concentration in patients with chronic myeloid leukemia. Blood 2004; 104: 495–501
   PubMed Web of Science ®Google Scholar
• Dolci S, Pellegrini M, Di Agostino S, Geremia R, Rossi P. Signaling through extracellular signal-regulated kinase is required for spermatogonial proliferative response to stem cell factor. J Biol Chem 2001; 276: 40225–40233
   PubMed Web of Science ®Google Scholar
• List A F, Glinsmann-Gibson B, Stadheim C, Meuillet E J, Bellamy W, Powis G. Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase-dependent clonogenic response in acute myeloid leukemia cells. Exp Hematol 2004; 32: 526–535
   PubMed Web of Science ®Google Scholar
• Spiekermann K, Bagrintseva K, Schwab R, Schmieja K, Hiddemann W. Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cells. Clin Cancer Res 2003; 9: 2140–2150
   PubMed Web of Science ®Google Scholar
• Takahashi M, Matsui A, Inao M, Mochida S, Fujiwara K. ERK/MAPK-dependent PI3K/AKT phosphorylation through VEGFR-1 after VEGF stimulation in activated hepatic stellate cells. Hepatol Res 2003; 26: 232–236
   PubMed Web of Science ®Google Scholar
• Riesterer O, Zingg D, Hummerjohann J, Bodis S, Pruschy M. Degradation of PKB/AKT protein by inhibition of the VEGF receptor/mTOR pathway in endothelial cells. Oncogene 2004; 23: 4624–4635
   PubMed Web of Science ®Google Scholar